GOLDMAN SACHS GROUP INC

Holdings History for Kymera Therapeutics, Inc. - Common Stock (KYMR)

Symbol: KYMR on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$57,603,210	740,306	+28,862	+4.1%	$77.81	Q4 2025
30 Sep 2025	0.01%	+0%	$40,267,730	711,444	+432,708	+155%	$56.60	Q3 2025
30 Jun 2025	0%	-0%	$12,164,039	278,736	-65,501	-19%	$43.64	Q2 2025
31 Mar 2025	0%	-0%	$9,421,766	344,237	-89,707		$27.37	Q1 2025
31 Dec 2024	0%	+0%	$17,457,567	433,944	+209,113	+93%	$40.23	Q4 2024
30 Sep 2024	0%	-0%	$10,641,251	224,831	-237,478	-51%	$47.33	Q3 2024
30 Jun 2024	0%	+0%	$13,799,924	462,309	+11,791	+2.6%	$29.85	Q2 2024
31 Mar 2024	0%	-0%	$18,110,823	450,518	-224,137	-33%	$40.20	Q1 2024
31 Dec 2023	0%	+0%	$17,176,716	674,655	+469,947	+230%	$25.46	Q4 2023
30 Sep 2023	0%	-0%	$2,845,441	204,708	-136,837	-40%	$13.90	Q3 2023
30 Jun 2023	0%	+0%	$7,852,120	341,545	+44,702	+15%	$22.99	Q2 2023
31 Mar 2023	0%	-0%	$8,795,458	296,843	-41,087	-12%	$29.63	Q1 2023
31 Dec 2022	0%	+0%	$8,434,733	337,930	+1,171	+0.35%	$24.96	Q4 2022
30 Sep 2022	0%	+0%	$7,331,000	336,759	+59,495	+21%	$21.77	Q3 2022
30 Jun 2022	0%	+0%	$5,459,000	277,264	+33,338	+14%	$19.69	Q2 2022
31 Mar 2022	0%	-0%	$10,323,000	243,926	-23,864	-8.9%	$42.32	Q1 2022
31 Dec 2021	0%	+0%	$17,002,000	267,790	+87,583	+49%	$63.49	Q4 2021
30 Sep 2021	0%	+0%	$10,585,000	180,207	+100,204	+125%	$58.74	Q3 2021
30 Jun 2021	0%	+0%	$3,881,000	80,003	+65,507	+452%	$48.51	Q2 2021
31 Mar 2021	0%	-0%	$563,000	14,496	-13,434	-48%	$38.84	Q1 2021
31 Dec 2020	0%	-0%	$1,732,000	27,930	-119,808	-81%	$62.01	Q4 2020
30 Sep 2020	0%	+0%	$4,773,000	147,738	+147,738	NEW	$32.31	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.